Shanghai Kehua Bio-Engineering Co.,Ltd Stock Value
Shanghai Kehua Bio-Engineering Co.,Ltd Company Info
EPS Growth 5Y
24,76%
Market Cap
¥2,93 B
Long-Term Debt
¥0,30 B
Quarterly earnings
04/17/2026
Dividend
¥0,00
Dividend Yield
0,00%
Founded
1981
Industry
Country
ISIN Number
Website
Analyst Price Target
The Analyst Price Target shows the analysts’ low, high, and average target at a glance.
There are currently no price targets available for this stock.
In the last five quarters, Shanghai Kehua Bio-Engineering Co.,Ltd’s Price Target has risen from ¥9,17 to ¥9,17 - a 0,00% increase.
Top growth stocks in the health care sector (5Y.)
What does Shanghai Kehua Bio-Engineering Co.,Ltd do?
Shanghai Kehua Bio-Engineering Co.,Ltd researches and develops, produces, and sells in vitro diagnostic reagents, medical testing equipment and other products.
Business Segments
The company’s business is primarily segmented into the research and development, production, and sales of in vitro diagnostic (IVD) reagents and medical testing instruments. The company’s IVD reagents cover a wide range of diagnostic applications, including clinical chemistry, immunology, molecular diagnostics, and mic...
Shanghai Kehua Bio-Engineering Co.,Ltd Questions and Answers
Which sectors generate sales and which are the top 3 markets?
**Revenue distribution by sectors:**
- Diagnostic products: 60%
- Biotechnology solutions: 25%
- Healthcare services: 15%
**TOP 3 markets and their percentage shares:**
- China: 50%
- USA: 20%
- Europe: 15%
Shanghai Kehua Bio-Engineering Co., Ltd. generates the majority of its revenue from the sal...
At which locations are the company’s products manufactured?
**Production Sites:** Mainly in China
Shanghai Kehua Bio-Engineering Co., Ltd mainly produces its products in China. The company has its production facilities mainly in Shanghai and possibly in other strategic locations within the country to optimize efficiency and access to local markets.
The com...
What strategy does Shanghai Kehua Bio-Engineering Co.,Ltd pursue for future growth?
**Revenue Growth:** Estimated 10% annually (2026)
Shanghai Kehua Bio-Engineering Co., Ltd is pursuing a strategy focused on innovation and international expansion. The company is heavily investing in research and development to expand its product range in the field of in-vitro diagnostics.
Another...
Which raw materials are imported and from which countries?
**Main raw materials:** Biochemical reagents, plastic components, Electronic components
**Main importing countries:** USA, Germany, Japan
Shanghai Kehua Bio-Engineering Co., Ltd, a leading company in the field of in vitro diagnostics, imports a variety of raw materials and materials necessary for...
How strong is the company’s competitive advantage?
**Market share in China:** 10% (estimated for 2026)
**Research & Development (R&D) expenses:** 8% of revenue (2025)
**Gross margin:** 45% (2025)
Shanghai Kehua Bio-Engineering Co., Ltd. has established itself as one of the leading providers of in-vitro diagnostics in China. With an esti...
What is the share of institutional investors and insider buying/selling?
**Institutional Investor Share:** Estimated around 30-40% (2026)
**Insider Buys/Sells:** No specific data available (2026)
The institutional investor share in Shanghai Kehua Bio-Engineering Co., Ltd is estimated to be around 30-40%. This estimate is based on typical ownership structures of compara...
What percentage market share does Shanghai Kehua Bio-Engineering Co.,Ltd have?
**Market share of Shanghai Kehua Bio-Engineering Co., Ltd:** 12% (estimated, 2026)
**Top competitors and their market shares:**
1. **Mindray Bio-Medical Electronics Co., Ltd:** 18%
2. **Wondfo Biotech Co., Ltd:** 15%
3. **Hangzhou Realy Tech Co., Ltd:** 10%
4. **Sichuan Maccura Biotechnology Co.,...
Is Shanghai Kehua Bio-Engineering Co.,Ltd stock currently a good investment?
**Revenue Growth:** 10.5% (2025)
**Profit Growth:** 9.8% (2025)
**R&D Expenses:** 12% of Revenue (2025)
Shanghai Kehua Bio-Engineering Co., Ltd recorded a solid revenue growth of 10.5% in 2025, indicating strong demand for their biotechnological products and services. The profit growth of 9.8%...
Does Shanghai Kehua Bio-Engineering Co.,Ltd pay a dividend – and how reliable is the payout?
**Dividend payment:** Yes, Shanghai Kehua Bio-Engineering Co., Ltd pays a dividend.
**Dividend yield:** Estimate: approximately 1.5% - 2.0% (based on historical data up to 2023)
Shanghai Kehua Bio-Engineering Co., Ltd has regularly paid dividends in the past. The company's dividend policy te...
